Knowing this, it can be inferred that resveratrol possesses the potential to inhibit CD44‐induced metastasis and treatment resistance within cervical cancer cells, whilst indirectly enhancing sensitivity to chemotherapy drugs such as carboplatin. The gene discussed is CD44; the disease is cervical carcinoma.